Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis

Journal of Hepatology

Volumn 27, Issue 2, 1997, Pages 391-398

  Pines, Mark ^a   Knopov, Viktor ^a   Genina, Olga ^a   Lavelin, Irina ^a   Nagler, Arnon ^b  

^a VOLCANI CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Collagen; Fibrosis; Plant alkaloid

Indexed keywords

COLLAGEN TYPE 1; DIMETHYLNITROSAMINE; HALOFUGINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE EXPRESSION; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030759740     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80186-9     Document Type: Article

References (44)

1. Friedman SL. The cellular basis of hepatic fibrosis. Mechanism and treatment strategies. N Engl J Med. 328:1993;1828-1835.
2. Achuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis. 10:1990;1-10.
3. Aycock RS, Seyer JM. Collagen of normal and cirrhotic human liver. Connect Tissue Res. 23:1989;19-31.
4. Panduro A, Shalaby F, Biempica L, Shafritz DA. Changes in albumin, alpha-fetoprotein and collagen gene transcription in CCl4-induced hepatic fibrosis. Hepatology. 8:1988;259-266.
5. Brenner DA, Westwick J, Breindl M. Type I collagen gene regulation and molecular pathogenesis of cirrhosis. Am J Physiol. 264:1993;G589-G595.
6. Bedosa P, Houglum K, Trautwein C, Holstege A, Chojkier M. Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology. 19:1994;1262-1271.
7. Annoni F, Weiner FR, Colombo M, Czaja MJ, Zern AM. Albumin and collagen gene regulation in alcohol- and virus-induced human liver disease. Gastroenterology. 98:1990;197-202.
8. Castilia A, Prieto J, Fausto N. Transforming growth factor β and α in chronic liver-disease-effects of interferon therapy. N Engl J Med. 324:1991;933-940.
9. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells. A potential mechanism of self-perpetuation in liver fibrogenesis. J Clin Invest. 89:1992;19-27.
10. Nagy P, Schaff Z, Lapis K. Immunohistochemical detection of transforming growth factor β1 in fibrotic liver disease. Hepatology. 14:1991;269-273.
11. Brecher AS, Hinko A, Twining SS. A proposed sequence of reactions leading to collagen biosynthesis, fibrosis and hypertension in alcoholics. J Invest Med. 44:1996;36-41.
12. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, Yla-Herttuala S, et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest. 96:1995;620-630.
13. Ala-Kokko L, Pihlajaniemi T, Myers JC, Kivirikko KI, Savolainen E. Gene expression of type I, III, and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J. 244:1987;75-79.
14. George J, Chandrakasan G. Molecular characteristics of dimethylnitrosamine-induced fibrotic liver collagen. Biochim Biophys Acta. 1292:1996;215-222.
15. Ramadori G, Knittel T, Odenthal M, Schwogler S, Neubauer K, Meyer Zum Büschenfelde KH. Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology. 103:1992;1313-1321.
16. Burt AD. Cellular and molecular aspects of hepatic fibrosis. J Pathol. 170:1993;105-114.
17. Lissoos TW, Beno DW, Davis BH. Hepatic fibrogenesis and its modulation by growth factors. J Pediatr Gastroenterol Nutr. 15:1992;225-231.
18. Mavier P, Mallat A. Perspectives in the treatment of liver fibrosis. J Hepatol. 22:1995;111-115.
19. Granot I, Bartov I, Plavnik I, Wax E, Hurwitz S, Pines M. Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone. Poult Sci. 70:1991;1559-1563.
20. Levi-Schaffer F, Nagler A, Slavin S, Knopov V, Pines M. Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone. J Invest Dermatol. 106:1996;84-88.
21. vivo by halofuginone. Am J Respir Crit Care Med. 154:1996;1082-1086.
22. Nyska M, Nyska A, Rivlin E, Porat S, Pines M, Shoshan S, et al. Topically applied halofuginone, an inhibitor of collagen type I transcription, reduced peritendinous fibrous adhesions following surgery. Connect Tissue Res. 34:1996;97-103.
23. Granot I, Hurwitz S, Halevy O, Pines M. Halofuginone: an inhibitor of collagen type I synthesis. Biochim Biophys Acta. 1156:1993;107-112.
24. Halevy O, Nagler A, Levi-Schaffer F, Genina O, Pines M. Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone. Biochem Pharmacol. 52:1996;1057-1063.
25. Choi ET, Callow AD, Sehgal NL, Brown DM, Ryan US. Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intima hyperplasia. Arch Surg. 130:1995;257-261.
26. Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem. 118:1995;643-649.
27. Krom MD. Spectrophotometric determination of ammonia: a study of a modified Berthelot reaction using salicylate and dichloroisocyanurate. Analyst. 105:1980;305-316.
28. Gascon-Barre M, Huet PM, Belgiorno J, Plourde V, Coulombe PA. Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats. J Histochem Cytochem. 37:1989;377-381.
29. Pines M, Knopov V, Bar A. Involvement of osteopontin in egg shell formation in the laying chicken. Matrix Biol. 14:1996;765-771.
30. Jezequel AM, Mancini R, Tinaldesi R, Macarri ML, Venturini C, Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol. 5:1987;174-181.
31. Hamalainen L, Oikarinen J, Kivirikko KI. Synthesis and degradation of type I procollagen mRNAs in cultured human skin fibroblasts and the effect of cortisol. J Biol Chem. 260:1985;720-725.
32. Weiner FR, Czaja MJ, Giambrone MA, Takahashi S, Biempica L, Zern MA. Transcriptional and posttranscriptional effects of dexamethasone on albumin and procollagen messenger RNAs in murine schistosomiasis. Biochemistry. 26:1987;1557-1562.
33. Gressner AM. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int. 49:1996;S39-S45.
34. Negler A, Miao HQ, Eingorn H, Pines M, Genina O, Vlodavsky I, et al. Inhibition of collagen synthesis, smooth muscle cell proliferation and injury induced intimal hyperplasia by halofuginone. Artersioscler Thromb Vasc Biol. 17:1997;194-202.
35. Simkevich CP, Thompson JP, Poppleton H, Raghow R. The transcriptional tissue specificity of the human proa1(I) collagen gene is determined by a negative cis-regulatory element in the promoter. Biochem J. 286:1992;179-185.
36. Jimenez S, Varga J, Olsen A, Li L, Diaz A, Herhal J, et al. Functional analysis of human a1(I) procollagen gene promoter: differential activity in collagen-producing and non-producing cells and response to transforming growth factor β1. J Biol Chem. 269:1994;12684-12691.
37. Chu M, DeWet W, Bernard M, Ramirez F. Fine structural analysis of the human pro-alpha 1(I) collagen gene. J Biol Chem. 260:1985;2315-2320.
38. Hatamochi A, Paterson B, de Crombrugghe B. Differential binding of a CCAAT DNA binding factor to the promoters of the mouse alpha 2(I) and alpha 1(III) collagen genes. J Biol Chem. 261:1986;11310-11314.
39. Boast SM, Su W, Ramirez F, Sanchez M, Avvedimento EV. Functional analysis of cis-acting DNA sequences controlling transcription of the human type I collagen genes. J Biol Chem. 265:1990;13351-13356.
40. Karsenty G, de Crombrugghe B. Two different negative and one positive regulatory factors interact with a short promoter segment of the α1(I) collagen gene. J Biol Chem. 265:1990;9934-9942.
41. Rippe RA, Lorenzen S, Brenner DA, Breindel M. Regulatory elements in the 5′-flanking region and the first intron contribute to transcriptional control of the mouse alpha 1 type I collagen gene. Mol Cell Biol. 9:1989;2224-2227.
42. Palvin D, Lichtler AC, Bedalov A, Kream BE, Harrison JR, Thomas HF, et al. Differential utilization of regulatory domains within the α1(I) collagen promoter in osseous and fibroblastic cells. J Cell Biol. 116:1992;227-236.
43. Armendariz-Borunda J, Katayama K, Seyer JM. Transcriptional mechanism of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor beta and transforming growth factor beta in Ito cells. J Biol Chem. 267:1992;14316-14321.
44. Armendariz-Borunda J, Simkevich CP, Roy N, Raghow R, Kang AH, Seyer JM. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J. 304:1994;817-824.